During the past decade, Baptist Health South Florida conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baptist Health South Florida" #1 sponsor was "Memorial Sloan Kettering Cancer Center" with 2 trials, followed by "Agendia" with 1 trials sponsored, "Arthrex, Inc." with 1 trials sponsored, "Astellas Pharma Global Development, Inc." with 1 trials sponsored and "ConforMIS, Inc." with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baptist Health South Florida" #1 collaborator was "Baptist Health South Florida" with 2 trials as a collaborator, "Anne Arundel Medical Center" with 1 trials as a collaborator, "Hackensack Meridian Health" with 1 trials as a collaborator, "Hartford HealthCare" with 1 trials as a collaborator and "Lahey Hospital & Medical Center" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Baptist Health South Florida" are "Acute Ischemic Stroke" (1 trials), "Bariatric - Sleeve Gastrectomy Staple Line Reinforcement" (1 trials), "Benign Hysterectomy" (1 trials), "Breast Cancer" (1 trials) and "Cardiogenic Shock" (1 trials). Many other conditions were trialed in "Baptist Health South Florida" in a lesser frequency.

Most popular intervention types in "Baptist Health South Florida" are "Device" (11 trials), "Drug" (4 trials), "Procedure" (3 trials), "Behavioral" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "BluePrint 80 gene expression profile" (1 trials), "Cannula and Blunt Obturator" (1 trials), "Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC)" (1 trials), "Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System" (1 trials) and "Catheter-Directed Thrombolysis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Health South Florida" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Baptist Health South Florida". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Baptist Health South Florida, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Health South Florida, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".